Group 6 Copy 425
0
    Please wait...

    About This Project

    OncoSynergy, Inc.
    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    When Does the Eel River Turn Toxic? Patterns in Cyanotoxin Occurrence 2013-2016

    The Eel River, California's third largest river, is famous for its salmon and steelhead runs. Since about...

    Whale snot and blubber: Tools used to better understand basic physiology in free ranging cetaceans

    Baseline indices for steroid hormone levels in humpback whales do not exist, and current monitoring techniques...

    Backer Badge Funded

    A biology project funded by 47 people